Patients with refractory out-of-hospital cardiac arrest (OHCA) receiving “hyperinvasive” rather than standard care had better overall outcomes, researchers in the randomized Prague OHCA trial conclude. The primary endpoint, survival at 180 days with a favorable neurologic outcome, defined as a cerebral performance category (CPC) score of 1 or 2, was numerically higher with the hyperinvasive […]